Table 4.
Value of life lost due to cancer deaths in the years 2000 and 2020 by tumor site in billions of dollars*
| Tumor site | Value of life lost | % increase in value of life lost | |
| 2000 (billion $) | 2020 (billion $) | ||
| Lung | 270.8 | 433.4 | 60.1 |
| Female breast | 85.3 | 121.0 | 41.8 |
| Prostate | 34.8 | 58.4 | 67.6 |
| Colorectal | 90.9 | 140.1 | 54.3 |
| Pancreas | 49.9 | 77.9 | 56.2 |
| Ovary | 27.7 | 41.0 | 48.1 |
| Leukemia | 38.0 | 55.4 | 45.9 |
| Lymphoma (non-Hodgkin) | 37.4 | 56.5 | 51.0 |
| Esophagus | 22.0 | 34.9 | 58.6 |
| Urinary bladder | 16.7 | 26.7 | 60.2 |
| Liver | 24.6 | 37.2 | 51.4 |
| Kidney | 21.0 | 32.6 | 54.9 |
| Gastric | 20.8 | 31.6 | 51.5 |
| Head and neck | 18.4 | 28.7 | 56.3 |
| Brain and ONS | 28.9 | 40.5 | 40.1 |
| Cervix | 10.5 | 13.5 | 28.7 |
| Corpus uteri | 12.1 | 18.5 | 52.4 |
| Melanoma of the skin | 15.1 | 21.6 | 42.8 |
| Lymphoma (Hodgkin) | 3.2 | 4.3 | 31.0 |
| Testis | 1.2 | 1.3 | 13.6 |
| All cancers | 960.7 | 1472.5 | 53.3 |
*
Tumor sites are listed from highest to lowest sex-specific age-adjusted mortality rate. ONS = other neurologic sites. Value of life lost was estimated using a previously published value of 1 year of life ($150 000) applied to the person-years of life lost estimate for each tumor site. All value of life lost estimates were discounted by 3% annually and reported in real dollars.